Am learning thru your comments on Lilly psoriasis product development and my talk with a friend re: Novartis cancer treatment products that in biotech many firms can be working on the same medial problem but due to the different approaches to each the developments can be starkly different and certainly not comparing apples to apples.  If we look at our products, I think we have two "Honey Crisp" or "Fuji" apples as they are some of my favorites.

Thanks for the feedback.